. . . . . . . . . . . "p(HGNC:BCL2) -| bp(MESHPP:Apoptosis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Vascular Endothelial Growth Factor in Oncology 2004 Aug 1(2) 3-6" . "Vascular Endothelial Growth Factor in Oncology 2004 Aug 1(2) 3-6" . "Other" . "VEGF has been shown to promote endothelial cell survival by inhibiting apoptosis pathways, upregulating antiapoptotic proteins such as BCL2 and survivin, and activating proteins such as focal adhesion kinase that maintain endothelial cell survival despite apoptotic stimuli" . . "Selventa" . . . . "2014-07-03T14:29:44.880+02:00"^^ . . .